Evidence map›Paper›PMID 41997973›Full record

ArticleScientific reports2026

Morphological and nanomechanical insights into the selective targeting of breast cancer cells by novel nickel ferrite nanoparticles.

Samia Dhahri, Yassine Messat, Richard Younes, Farah Nasraoui, Manel Othman, Frederic J G Cuisinier, Csilla Gergely, Najeh Thabet Mliki, Marta Martin, Elias Estephan

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samia DhahriLaboratory of Materials Organization and Properties (LMOP), Faculty of Science of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia. samia.dhahri@esstst.utm.tn.
Yassine MessatLaboratoire Bioingénierie Nanosciences (LBN), Université de Montpellier, Montpellier, France.
Richard YounesLaboratoire Bioingénierie Nanosciences (LBN), Université de Montpellier, Montpellier, France.
Farah NasraouiLaboratory of Materials Organization and Properties (LMOP), Faculty of Science of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia.
Manel OthmanLaboratory of Materials Organization and Properties (LMOP), Faculty of Science of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia.
Frederic J G CuisinierLaboratoire Bioingénierie Nanosciences (LBN), Université de Montpellier, Montpellier, France.
Csilla GergelyLaboratoire Charles Coulomb (L2C), CNRS, Université de Montpellier, Montpellier, France.
Najeh Thabet MlikiLaboratory of Materials Organization and Properties (LMOP), Faculty of Science of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia.
Marta Martin *Laboratoire Charles Coulomb (L2C), CNRS, Université de Montpellier, Montpellier, France.
Elias Estephan *Laboratoire Bioingénierie Nanosciences (LBN), Université de Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nickel Ferrite nanoparticles (NPs) have great potential for biomedical applications. These spinel ferrites exhibit unique physicochemical, magnetic and biocompatible properties that enable them to interact with biological cells. We report the use of immunofluorescence microscopy and Atomic Force Microscopy (AFM) in liquid to study their anticancer activity on live cells. Magnetic NPs were synthesized using novel solvothermal and hydrothermal routes, yielding sizes distributions centered at 8.6 ± 1.5 nm and 37.4 ± 1.5 nm, respectively. Their effect on the MCF-7 human breast cancer cells and the non-tumorigenic epithelial MCF-10 cell line was examined by monitoring morphological and nanomechanical responses using AFM. Complementary immunofluorescence microscopy observations and cell viability assays provided broader insights into their biological effects on a larger cell culture. Nickel ferrite NPs significantly altered nanomechanical properties and reduced viability of MCF-7 cancer cells. In contrast, they had minimal effect on healthy MCF-10 cells, as confirmed by AFM (cell height, RMS, and Young's modulus), immunofluorescence, and viability assays. Together, these results highlight a selective anticancer activity of these novel nickel ferrite NPs, supporting their potential as a sustainable and biocompatible alternative to conventional anticancer drugs.

Indexed as

Antineoplastic AgentsBreast NeoplasmsFerric CompoundsNanoparticlesNickelCell Line, TumorCell SurvivalFemaleHumansMCF-7 CellsMicroscopy, Atomic ForceAntineoplastic AgentsFerric CompoundsNickelnickel ferriteAFMAntiproliferativeBreast cancer cellsBreast epithelial cellsFerritesMagnetic nanoparticlesNanotechnologyTumoricidal

Identifiers

PMID41997973
PMCPMC13247270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.